Archives: Agenda

• Aligning advocacy and industry to shape better trials that reflect the real world
• Protecting patient rights in an increasingly data-driven trial environment, from informed consent and data ownership to transparency over how patient data is collected and shared
• Balancing the use of patient data and AI with transparency, trust, and patient control to ensure new technologies enhance rather than complicate the patient experience
• Moving beyond standardized touchpoints to deliver more responsive and human-centered patient support

• Bringing the patient voice into every stage of development and embedding patient advocates from day one, moving from feedback to true co-creation across the trial lifecycle
• Breaking down barriers in access, diversity, and language to expand participation, build trust, and make trials truly patient-centered
• Simplifying participation and communication to reduce burden, improve understanding, and generate richer, more meaningful data
• Leveraging patient experiences to help change the landscape, making clinical trials better for patients worldwide

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

• Effectively championing adaptive trial designs to stay nimble as the clinical research landscape continues to evolve
• Streamlining protocol finalization, regulatory submissions, and feasibility assessments to shorten start-up timelines
• Identifying and engaging the right sites as part of a broader operational readiness strategy
• Coordinating cross-functional teams, vendor partnerships, and internal stakeholders to ensure smooth study initiation
• Implementing robust onboarding, training, and communication plans to set the trial up for success from day one
• Reducing contract cycle times to accelerate study start-up

Moderator: Michael Murphy, Director, Legal & Associate General Counsel, Ionis

Sponsored by Suvoda

With drinks and refreshments, interactive breakout sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run twice and be led by a table moderator and will focus on a different challenge within clinical trials. Breakout discussions are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

This panel will take place in TRACK A: Outsourcing & Clinical Operations

1 stage, a variety of rapid-fire opinions, bold predictions and myth-busting from experts across the industry. Audience members will vote, agree or disagree, on each hot take! There’ll be a chance for the audience to pose some questions to the panel too.

The panel will answer the following:

• Biggest mistake in clinical trials today
• One thing pharma should stop doing
• One prediction for 2030
• What’s overhyped and what’s worth the hype
• What vendors misunderstand
• Where trials fail most often
• Biggest recruitment mistake
• Hot takes from the audience

Moderator: Robert Loll, SVP, Business Development & Strategic Planning, Praxis

• Better RFP specifications lead to better proposals, pricing, timelines, and accountability.
• The protocol is not the specification, define the operational assumptions CROs need to price and plan accurately.
• Separate requirements, assumptions, and CRO recommendations so proposals can be compared consistently.
• Standardize bid grids and key assumptions while still allowing CROs to propose differentiated solutions.
• Surface exclusions, dependencies, and hidden assumptions early, these are often the source of future change orders.
• Build uncertainty into the RFP with scenarios for sites, countries, enrollment, timelines, and amendments.
• Use the RFP and bid defense to test how the CRO thinks, not just what they charge.
• Carry proposal commitments into the contract, governance plan, KPIs, and operating model.
• The goal is not simply a better bid, it is better communication, fewer surprises

• Identify protocol risks earlier through integrated clinical, operational and site-level perspectives.
• Design more executable studies by aligning protocol ambition with real-world site and patient needs.
• Reduce avoidable delays, amendments and costs by building feasibility into the protocol from the outset.